All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

AFT Pharmaceuticals Limited revenue reports

AFT Pharmaceuticals Limited financial reports, AFT Pharmaceuticals Limited annual revenue in 2024. When does AFT Pharmaceuticals Limited report revenue?
Add to widgets
Added to widgets

AFT Pharmaceuticals Limited total revenue, net income and dynamics of changes in New Zealand dollar today

AFT Pharmaceuticals Limited revenue for the past few reporting periods. The dynamics of AFT Pharmaceuticals Limited net revenue has changed by 0 $ over the last period. Net income of AFT Pharmaceuticals Limited today amounted to 3 295 000 $. AFT Pharmaceuticals Limited net income is shown in blue on the graph. All information on AFT Pharmaceuticals Limited total revenue on this chart is created in the form of yellow bars. The value of all AFT Pharmaceuticals Limited assets on the graph is shown in green.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 32 142 000 $ +36.54 % ↑ 3 295 000 $ +274.22 % ↑
31/12/2020 32 142 000 $ +36.54 % ↑ 3 295 000 $ +274.22 % ↑
30/09/2020 24 410 500 $ +3.99 % ↑ 596 000 $ -87.967 % ↓
30/06/2020 24 410 500 $ +3.99 % ↑ 596 000 $ -87.967 % ↓
30/09/2019 23 473 000 $ - 4 953 000 $ -
30/06/2019 23 473 000 $ - 4 953 000 $ -
31/03/2019 23 541 000 $ - 880 500 $ -
31/12/2018 23 541 000 $ - 880 500 $ -
Show:
to

AFT Pharmaceuticals Limited financial report charts

The latest dates of AFT Pharmaceuticals Limited financial statements available online: 31/12/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of AFT Pharmaceuticals Limited is available online for such a date - 31/03/2021. Gross profit AFT Pharmaceuticals Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit AFT Pharmaceuticals Limited is 14 204 500 $

AFT Pharmaceuticals Limited quarterly report dates

Cost of revenue AFT Pharmaceuticals Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue AFT Pharmaceuticals Limited is 17 937 500 $ Total revenue AFT Pharmaceuticals Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue AFT Pharmaceuticals Limited is 32 142 000 $ Operating income AFT Pharmaceuticals Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income AFT Pharmaceuticals Limited is 4 143 000 $

Net income AFT Pharmaceuticals Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income AFT Pharmaceuticals Limited is 3 295 000 $ Current assets AFT Pharmaceuticals Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets AFT Pharmaceuticals Limited is 67 902 000 $ Total assets AFT Pharmaceuticals Limited refers to the total amount of assets owned by a person or entity. Total assets AFT Pharmaceuticals Limited is 105 132 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
14 204 500 $ 14 204 500 $ 10 166 000 $ 10 166 000 $ 10 674 000 $ 10 674 000 $ 11 488 500 $ 11 488 500 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
17 937 500 $ 17 937 500 $ 14 244 500 $ 14 244 500 $ 12 799 000 $ 12 799 000 $ 12 052 500 $ 12 052 500 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
32 142 000 $ 32 142 000 $ 24 410 500 $ 24 410 500 $ 23 473 000 $ 23 473 000 $ 23 541 000 $ 23 541 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 23 473 000 $ 23 473 000 $ 23 541 000 $ 23 541 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
4 143 000 $ 4 143 000 $ 1 211 000 $ 1 211 000 $ 1 993 500 $ 1 993 500 $ 3 201 000 $ 3 201 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
3 295 000 $ 3 295 000 $ 596 000 $ 596 000 $ 4 953 000 $ 4 953 000 $ 880 500 $ 880 500 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
789 500 $ 789 500 $ 929 000 $ 929 000 $ 111 500 $ 111 500 $ -655 500 $ -655 500 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
27 999 000 $ 27 999 000 $ 23 199 500 $ 23 199 500 $ 21 479 500 $ 21 479 500 $ 20 340 000 $ 20 340 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
67 902 000 $ 67 902 000 $ 58 549 000 $ 58 549 000 $ 54 806 000 $ 54 806 000 $ 51 261 000 $ 51 261 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
105 132 000 $ 105 132 000 $ 93 983 000 $ 93 983 000 $ 83 230 000 $ 83 230 000 $ 63 595 000 $ 63 595 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
3 209 000 $ 3 209 000 $ 5 870 000 $ 5 870 000 $ 7 308 000 $ 7 308 000 $ 6 916 000 $ 6 916 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 65 015 000 $ 65 015 000 $ 58 504 000 $ 58 504 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 68 648 000 $ 68 648 000 $ 58 504 000 $ 58 504 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 82.48 % 82.48 % 91.99 % 91.99 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
36 588 000 $ 36 588 000 $ 29 886 000 $ 29 886 000 $ 13 087 000 $ 13 087 000 $ -5 274 000 $ -5 274 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 3 067 500 $ 3 067 500 $ 2 437 000 $ 2 437 000 $

Last revenue report of AFT Pharmaceuticals Limited was 31/03/2021. According to last financial report total revenue in AFT Pharmaceuticals Limited was 32 142 000 New Zealand dollar and changed by +36.54% since last year. Net income in AFT Pharmaceuticals Limited was 3 295 000 $ in last quartal, net income changes to +274.22%.

Current cash AFT Pharmaceuticals Limited - the sum of all of the cash a company has on the date of report. Current cash AFT Pharmaceuticals Limited is 3 209 000 $

AFT Pharmaceuticals Limited stocks data

AFT Pharmaceuticals Limited financials